Imricor Medical Systems Inc
ASX:IMR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Imricor Medical Systems Inc
ASX:IMR
|
US |
|
Qube Holdings Ltd
ASX:QUB
|
AU |
|
G
|
Gold Resource Corp
AMEX:GORO
|
US |
|
B
|
Black Knight Inc
F:BKF
|
US |
|
CONSOL Energy Inc
NYSE:CEIX
|
US |
|
Delta Resources Ltd
XTSX:DLTA
|
CA |
|
R
|
Rane (Madras) Ltd
NSE:RML
|
IN |
|
Commercial Metals Co
NYSE:CMC
|
US |
|
Barrick Gold Corp
TSX:ABX
|
CA |
|
Ashland Inc
F:AHT
|
US |
|
Loblaw Companies Ltd
TSX:L
|
CA |
|
Vestas Wind Systems A/S
CSE:VWS
|
DK |
|
ERI Holdings Co Ltd
TSE:6083
|
JP |
|
Cloudflare Inc
NYSE:NET
|
US |
|
D
|
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
|
ID |
|
TORIDOLL Holdings Corp
TSE:3397
|
JP |
|
Step Co Ltd
TSE:9795
|
JP |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
Sectra AB
STO:SECT B
|
SE |
|
E
|
Euro Cervantes SOCIMI SA
MAD:YEUR
|
ES |
|
G
|
GBLT Corp
XTSX:GBLT
|
CA |
|
M
|
Marel hf
ICEX:MAREL
|
IS |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
Wall Street
Price Targets
IMR Price Targets Summary
Imricor Medical Systems Inc
According to Wall Street analysts, the average 1-year price target for
IMR
is 2.66 AUD
with a low forecast of 2.35 AUD and a high forecast of 2.92 AUD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IMR's stock price target?
Price Target
2.66
AUD
According to Wall Street analysts, the average 1-year price target for
IMR
is 2.66 AUD
with a low forecast of 2.35 AUD and a high forecast of 2.92 AUD.
What is Imricor Medical Systems Inc's Revenue forecast?
Projected CAGR
324%
For the last 8 years the
compound annual growth rate for
Imricor Medical Systems Inc's revenue is
-5%.
The projected
CAGR
for the next 3 years is
324%.
